EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nexinhib20 inhibits JFC1-mediated mobilization of a subset of CD11b/CD18+ vesicles decreasing integrin avidity, but does not inhibit Rac1

Kasra Askari, Jennifer L Johnson, Aparna Shukla, Elsa Meneses-Salas, William B Kiosses, Juan Yu, Sergio D Catz iD

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiaf012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Kasra Askari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States. Hauptthemen laut MEDLINE: rac1 GTP-Binding Protein, CD18 Antigens, Neutrophils, CD11b Antigen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, U.S. Public Health Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulated sequential exocytosis of neutrophil granules is essential for orchestrating the innate immune response, while uncontrolled secretion causes inflammation. We developed and characterized Nexinhib20, a small-molecule inhibitor that targets azurophilic granule exocytosis in neutrophils by blocking the interaction between the small GTPase Rab27a and its effector JFC1. Its therapeutic potential has been demonstrated in several preclinical models of inflammatory disease. Here, using neutrophils from Jfc1-KO mice, we show that JFC1 regulates the mobilization of a small subpopulation of CD11b+ granules. Nexinhib20 inhibits the mobilization of β2-integrins from a subset of CD11b+ granules to the plasma membrane in human and mouse neutrophils. The putative impact of Nexinhib20 on integrin activation is caused by decreased avidity, secondary to its effect on β2-integrin mobilization. CD11b mobilization and integrin activation were unaffected by pharmacological inhibition or activation of Rac1. Using quantitative 3D enhanced resolution microscopy, we show that neutrophil activation induces the recruitment of JFC1 to CD11b+ granules. Nexinhib20 decreased the localization of JFC1 at CD11b+ granules without affecting the association of Rac1 with CD11b. Nexinhib20 inhibits JFC1 recruitment but not endogenous Rac1 activation in living cells. Using orthogonal analyses of Rac1 activity consisting of a sensitive, time-resolved fluorescence energy transfer, Rac1-PAK1-binding assay, and endogenous Rac1-GTP examination, we show that Nexinhib20 does not interfere with Rac1 activation. Instead, we confirm its molecular mode of action as the inhibition of the Rab27a-JFC1 binding. Thus, Nexinhib20 limits β2-integrin mobilization to the cell surface, decreasing avidity and affecting active integrin availability in a JFC1-dependent but Rac1-independent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

rac1 GTP-Binding ProteinCD18 AntigensNeutrophilsCD11b AntigenSorting NexinsAnimalsHumansMiceMice, KnockoutMice, Inbred C57BLrab27 GTP-Binding ProteinsExocytosis

Stichwörter der Autor:innen

CD11bCD18Nexinhib20Rab GTPaseRac1adhesioncardiovasculardegranulationexocytosisinflammationinhibitorintegrinneutrophil

Substanzen

rac1 GTP-Binding ProteinCD18 AntigensCD11b Antigenrab27 GTP-Binding ProteinsSorting NexinsRab27a protein, mouse

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States.
  • Division of Inflammation Biology, La Jolla Institute for Immunology, 9420 Athena Cir, La Jolla, CA 92037, United States.

ORCID-Profile: Sergio D Catz

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • U.S. Public Health Service
  • NIH HHS
  • NIAMS NIH HHS
  • Shared Instrumentation Grant Program
  • Cystinosis Research Foundation
  • NIH

Zitieren

APA

Askari, K., Johnson, J. L., Shukla, A., Meneses-Salas, E., Kiosses, W. B., Yu, J., & Catz, S. D. (2025). Nexinhib20 inhibits JFC1-mediated mobilization of a subset of CD11b/CD18+ vesicles decreasing integrin avidity, but does not inhibit Rac1. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf012

Vancouver

Askari K, Johnson JL, Shukla A, Meneses-Salas E, Kiosses WB, Yu J, et al. Nexinhib20 inhibits JFC1-mediated mobilization of a subset of CD11b/CD18+ vesicles decreasing integrin avidity, but does not inhibit Rac1. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf012

BibTeX
@article{Askari2025,
  author = {Askari, Kasra and Johnson, Jennifer L and Shukla, Aparna and Meneses-Salas, Elsa and Kiosses, William B and Yu, Juan and Catz, Sergio D},
  title = {Nexinhib20 inhibits JFC1-mediated mobilization of a subset of CD11b/CD18+ vesicles decreasing integrin avidity, but does not inhibit Rac1},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiaf012}
}
Kostenlos starten →